A Recurrent Germline Mutation in the 5'UTR of the Androgen Receptor Causes Complete Androgen Insensitivity by Activating Aberrant uORF Translation

PLoS One. 2016 Apr 25;11(4):e0154158. doi: 10.1371/journal.pone.0154158. eCollection 2016.

Abstract

A subset of patients with monogenic disorders lacks disease causing mutations in the protein coding region of the corresponding gene. Here we describe a recurrent germline mutation found in two unrelated patients with complete androgen insensitivity syndrome (CAIS) generating an upstream open reading frame (uORF) in the 5' untranslated region (5'-UTR) of the androgen receptor (AR) gene. We show in patient derived primary genital skin fibroblasts as well as in cell-based reporter assays that this mutation severely impacts AR function by reducing AR protein levels without affecting AR mRNA levels. Importantly, the newly generated uORF translates into a polypeptide and the expression level of this polypeptide inversely correlates with protein translation from the primary ORF of the AR thereby providing a model for AR-5'UTR mediated translational repression. Our findings not only add a hitherto unrecognized genetic cause to complete androgen insensitivity but also underline the importance of 5'UTR mutations affecting uORFs for the pathogenesis of monogenic disorders in general.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 5' Untranslated Regions*
  • Androgen-Insensitivity Syndrome / genetics*
  • Androgen-Insensitivity Syndrome / metabolism
  • Androgen-Insensitivity Syndrome / pathology
  • Base Sequence
  • Fibroblasts / metabolism*
  • Fibroblasts / pathology
  • Frameshift Mutation
  • Gene Expression Regulation
  • Genes, Reporter
  • Germ-Line Mutation*
  • Humans
  • Luciferases / genetics
  • Luciferases / metabolism
  • Male
  • Open Reading Frames
  • Primary Cell Culture
  • Protein Biosynthesis*
  • Receptors, Androgen / genetics*
  • Receptors, Androgen / metabolism
  • Sequence Analysis, DNA

Substances

  • 5' Untranslated Regions
  • AR protein, human
  • Receptors, Androgen
  • Luciferases

Grants and funding

The study has been funded by the Medical Faculty of the Christian-Albrechts-University, CAU, Kiel, Germany (Forschungsförderung 2015 – Anschub to NH) and the German Research Council (Deutsche Forschungsgemeinschaft, DFG) (Ho2073/7-1/7-3 to PMH and AM 343/2-1/2-3 to OA). The authors thank the KinderKrebsInitiative Buchholz/Holm-Seppensen for providing infrastructure.